What did the University of Melbourne study find about GAHT?

The study found that feminizing GAHT significantly alters blood protein levels in transgender women, moving them closer to those found in cisgender women.

What are the potential long-term health risks of GAHT identified by the research?

The research suggests potential links between GAHT-induced protein changes and increased susceptibility to asthma and autoimmune disorders.

How new is the technology used in the GAHT protein study?

The technology for measuring thousands of proteins simultaneously is relatively new, having been available and affordable only for the past 2-3 years.

Home / Science / Hormone Therapy Alters Blood Proteins Deeply

Hormone Therapy Alters Blood Proteins Deeply

28 Nov

•

Summary

Gender-affirming hormone therapy significantly changes blood proteins.
Changes align transgender women's protein profiles with cisgender women.
Deeper biological shifts may influence long-term health risks.

Hormone Therapy Alters Blood Proteins Deeply

Groundbreaking research published in Nature Medicine demonstrates that feminizing gender-affirmative hormone therapy (GAHT) induces significant molecular changes within transgender women's bodies, extending to the very proteins found in their blood. The study, co-led by Ada Cheung, found that GAHT shifts protein levels, aligning them more closely with those observed in cisgender women, indicating a deeper biological effect than previously understood.

These profound changes are attributed to decreased testosterone, increased body fat, and altered breast volume resulting from GAHT. While these findings highlight GAHT's comprehensive impact, they also suggest potential predispositions to conditions like asthma and autoimmune disorders, mirroring higher risks in cisgender women. However, researchers stress that these are early molecular shifts, not confirmed clinical outcomes.

This world-first study utilized advanced proteomic technology to analyze thousands of proteins in blood samples from transgender women before and after six months of GAHT. The findings underscore the importance of inclusive, data-driven science in transgender healthcare. Future research aims to explore similar effects in masculinizing GAHT and to conduct longitudinal studies to ascertain real-world health implications.